Clinical Study of G Protein Biased Μ - Opioid Receptor Agonist Oliceridine for Optimizing Postoperative Analgesia Under General Anesthesia

ConditionOld Age
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorHenan Provincial People's Hospital

About this trial

Traditional opioid analgesia is a treatment method for moderate to severe pain. However, the use of opioid drugs is not without risks. When treating acute pain, patients may experience hypotension, respiratory depression, hypoxia, nausea and vomiting, irritability, and itching. The purpose of this study is to evaluate the comparison of G protein biased μ - opioid receptor agonist oliceridine and traditional μ - opioid receptor agonist sufentanil in terms of analgesia in patients under general anesthesia.

Eligibility criteria

Qualifiers

Age>65 years old

ASA Level I-III

BMI 18.5-29.9

Patients undergoing knee joint surface replacement surgery under general anesthesia

Disqualifiers

Suffering from chronic pain or mental illness before surgery

Unable to communicate due to cognitive impairment or language barriers before surgery

Patients who have used opioid drugs three days before surgery

Patients with long-term alcohol consumption

Trial design

Treatments tested in this trial

  • Oliceridine
  • Sulfentanil

Treatment groups

150 Participants
are divided into 2 treatment groups

Locations

This trial has no locations